Bloom Energy
BE
$142.39
-15.30%
Bloom Energy designs, manufactures, sells, and installs solid oxide fuel cell systems for on-site power generation, with its fuel-flexible Energy Servers running on natural gas, biogas, or hydrogen to deliver 24/7 stationary electricity to commercial, industrial, utility, and data-center customers, primarily in the United States with select international exposure. The company is a differentiated, capital-intensive niche player in the Electrical Equipment & Parts industry, competing against grid incumbents, gas turbines, and other distributed-generation technologies rather than against commodity battery or solar vendors, and its multi-year service and electricity contracts create a recurring-revenue layer atop hardware sales. The current investor narrative has shifted decisively toward Bloom as an AI-infrastructure power play: explosive Q3 2026 revenue growth, a reported ~$20 billion backlog, margin expansion, and October S&P 500 inclusion have driven a dramatic re-rating, but the stock has simultaneously sold off sharply from its highs as investors debate whether the premium valuation, negative quarterly free cash flow, and execution risk on a massive backlog are adequately compensated. Coverage from Motley Fool, Zacks, and sell-side desks frames the debate as "explosive growth versus rich valuation," with bulls pointing to data-center demand and bears flagging working-capital strain and a beta above 3.6.…
BE
Bloom Energy
$142.39
Related headlines
Investment Opinion: Should I buy BE Today?
Rating: Hold (accumulate selectively on weakness). The core thesis is that Bloom Energy's fundamentals have inflected decisively — 138.1% revenue growth to $1.236 billion in Q3 2026, gross margin expansion to 33.75%, and operating income of $225.4 million versus $7.8 million a year ago — but the stock's 10.32x PS multiple and -$180.6 million Q3 free cash flow mean the market is already paying for much of that success. The analyst consensus of "buy" (16 Buy / 12 Hold / 1 Sell, mean 2.17) with a $283.85 average target implying +60.1% upside anchors a constructive but not high-conviction view, and the 12 Hold ratings correctly reflect that this is a buy-with-caveats setup rather than a clean call.
Supporting evidence is genuinely strong on the operating line: revenue accelerated sequentially from $751.1 million in Q1 to $1.066 billion in Q2 to $1.236 billion in Q3 2026, gross margin climbed from 30.03% to 33.38% to 33.75% across those quarters, and EBITDA jumped to $271.1 million from $4.6 million a year earlier. A reported ~$20 billion backlog plus October S&P 500 inclusion provide multi-year visibility and passive-flow support, while the forward PE of 33.30x on consensus EPS of $13.78 is far more reasonable than the meaningless -234.8x trailing PE. Against sector norms, however, the 10.32x PS, 14.91x EV/Sales, and 27.18x P/B (versus a typical 2-4x book) remain a steep premium that requires flawless backlog conversion to justify.
The biggest risks that could invalidate the thesis are (1) persistent negative free cash flow — Q3's -$180.6 million came despite $250.3 million of net income, driven by a $356.0 million working-capital drain and $153.5 million of capex — (2) margin compression below 30% if competition from GE Vernova (96% order growth, $197 billion backlog) and grid alternatives intensifies, and (3) a de-rating toward the $102 analyst low target if execution slips. This Hold would upgrade to Buy if Q4 delivers positive free cash flow alongside gross margins holding above 33%, or if the stock pulls back toward the $150s (roughly 8-9x PS) without fundamental deterioration; it would downgrade to Sell on a break below the $167.52 November 5 close combined with a second consecutive negative-FCF quarter. Net verdict: the stock is fairly valued to modestly undervalued relative to its own historical PS band (7x-82x, currently 10.32x) but still expensive versus industrial peers — a reasonable risk/reward for growth-oriented investors, not a bargain.
Sign up to view all
BE 12-Month Price Forecast
The forward view is genuinely two-sided: operating momentum is exceptional (33.75% gross margin, $225.4M operating income versus $7.8M a year ago, ~$20B backlog), yet cash conversion is the swing factor, with Q3's -$180.6M FCF showing growth is currently consuming capital. Valuation is less stretched than the headline suggests — 10.32x PS sits in the lower-middle of Bloom's own history and the 33.30x forward PE reflects a falling multiple on rising earnings — but it remains a premium to industrial peers that demands execution. The 3.618 beta and -52.65% max drawdown mean position sizing dominates direction, and the wide $102-$380 target spread confirms low Street conviction on terminal value. I would upgrade to bullish on a positive-FCF Q4 with margins above 33%, and downgrade to bearish if FCF stays negative for a second consecutive quarter or gross margin breaks below 30%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Bloom Energy's 12-month outlook, with a consensus price target around $282.69 and implied upside of +98.5% versus the current price.
Average Target
$282.69
29 analysts
Implied Upside
+98.5%
vs. current price
Analyst Count
29
covering this stock
Price Range
$102 - $380
Analyst target range
Coverage is broad and leans bullish: 26 analysts cover Bloom Energy with 16 Buy, 12 Hold, and 1 Sell ratings, a consensus recommendation of "buy" and a recommendation mean of 2.17 (where lower is more bullish). The average target price of $283.85 implies roughly +60.1% upside from the current $177.28, a strikingly large gap that reflects how far the stock has fallen below where the Street's models sit. The consensus is therefore bullish in aggregate, but the 12 Hold ratings signal meaningful caution — this is a "buy with caveats" consensus rather than a high-conviction call.
The target range is exceptionally wide, from a low of $102.00 to a high of $380.00 — a spread of more than 3.7x — which signals very high uncertainty and low conviction on terminal value. The high target of $380 assumes successful conversion of the ~$20 billion backlog, sustained 30%+ gross margins, multiple expansion on AI-infrastructure enthusiasm, and continued S&P 500 inclusion tailwinds; the low target of $102 prices in margin compression, working-capital strain, competitive losses to gas turbines or grid solutions, and a de-rating toward industrial-peer multiples. Recent institutional actions show a modest positive tilt — Barclays upgraded to Overweight from Equal Weight on November 3, 2026, while RBC, JP Morgan, Morgan Stanley, and Bernstein maintained their ratings — but the absence of broad upgrades alongside a 43% drawdown suggests the Street is waiting for evidence of backlog conversion and positive free cash flow before turning more constructive. The wide dispersion and the gap between the $283.85 average target and the $177.28 price make this a high-risk, high-reward setup where position sizing matters as much as direction.
Bulls vs Bears: BE Investment Factors
The bull case currently rests on harder near-term evidence: 138.1% revenue growth, gross margin expansion to 33.75%, operating income of $225.4 million versus $7.8 million a year ago, a ~$20 billion backlog, and a $283.85 average analyst target implying +60.1% upside. The bear case is equally concrete but more forward-looking: Q3 free cash flow of -$180.6 million, 3.89x debt-to-equity, a 10.32x PS and 27.18x P/B that price in flawless execution, and a stock in a confirmed downtrend (-37.20% over six months, -52.65% max drawdown) with a 3.618 beta. On balance the fundamental evidence favors the bulls modestly, but the market's skepticism is rational given the cash-flow quality gap. The single most important tension is backlog conversion economics: whether Bloom can turn its ~$20 billion pipeline into revenue without further working-capital drain and negative quarterly FCF. If Q4 shows positive FCF alongside continued 30%+ gross margins, the re-rating case is strong; if working-capital strain persists, the premium multiple is vulnerable to a de-rating toward the $102 bear target.
Bullish
- Revenue inflecting at triple-digit rate: Q3 2026 revenue hit $1.236 billion, up 138.1% year-over-year from $519.0 million, with sequential acceleration from $751.1 million in Q1 to $1.066 billion in Q2. This is hardware-led growth tied to data-center and on-site generation deployments, confirming that AI-driven power demand is converting into real shipments rather than just narrative.
- Operating leverage driving margin expansion: Gross margin expanded to 33.75% in Q3 2026 from 29.22% a year earlier, while operating income jumped to $225.4 million (18.24% margin) from just $7.8 million. EBITDA of $271.1 million versus $4.6 million in the prior-year quarter shows a dramatic step-up in profitability as revenue scales against a largely fixed cost base.
- Analyst targets imply large upside: The $283.85 average target across 26 analysts implies roughly +60.1% upside from the current $177.28, with 16 Buy ratings against 12 Hold and 1 Sell (recommendation mean 2.17). Barclays upgraded to Overweight on November 3, 2026, signaling incremental institutional conviction even amid the drawdown.
- Massive backlog plus S&P 500 inclusion: A reported ~$20 billion backlog provides multi-year revenue visibility, and October S&P 500 inclusion broadens the passive-investor base and adds index-flow support. The backlog is the single biggest fundamental differentiator versus smaller distributed-generation peers.
Bearish
- Negative quarterly free cash flow: Q3 2026 free cash flow was -$180.6 million despite $250.3 million of net income, driven by a $356.0 million working-capital drain (inventory -$170.4 million, receivables -$175.2 million) and $153.5 million of capex. The TTM FCF of $440.2 million masks severe quarterly volatility, with Q2 at +$174.8 million and Q3 at -$180.6 million.
- Extreme valuation versus industrial peers: PS of 10.32x and EV/Sales of 14.91x are a substantial premium to typical capital-goods multiples in the low-to-mid single digits, and price-to-book of 27.18x dwarfs the sector norm of roughly 2-4x. Investors are paying a growth-stock multiple for a capital-intensive industrial business, defensible only if the backlog converts and margins hold.
- High leverage and negative trailing returns: Debt-to-equity stands at 3.89x with a trailing ROE of -11.51% and trailing net margin of -4.37%, reflecting the loss-making 2025 quarters still in the TTM window. The combination of high leverage and negative quarterly FCF means Bloom remains dependent on its $2.51 billion cash buffer and continued capital-market access to fund growth.
- Severe momentum breakdown and volatility: The stock is down 19.90% over one month, -15.18% over three months, and -37.20% over six months, with a -52.65% max drawdown from its high and a beta of 3.618. Relative strength versus SPY is -16.85 points over one month, and a short ratio of just 1.19 means there is no squeeze catalyst to arrest the decline.
BE Technical Analysis
Bloom Energy is in a violent, high-volatility uptrend that has rolled over into a corrective phase: the stock is up 58.44% over the trailing year and 79.63% year-to-date, yet it sits at just 36.9% of its 52-week range (low $75.70, high $351.28) with a current price of $177.28. That positioning — a stock that has more than doubled off its low but has surrendered roughly half its peak — is characteristic of a momentum leader in a sharp mean-reversion drawdown rather than a clean trend or a value setup; the maximum drawdown of -52.65% confirms the severity of the reversal from the highs. For trend followers, the primary uptrend is technically broken until the stock reclaims intermediate resistance, while for value-oriented buyers the 36.9% range position offers a far better entry than the June-July peak above $345.
Short-term momentum is decisively negative and decelerating: the stock is down 19.90% over the past month, -15.18% over three months, and -37.20% over six months, with today's session alone down 7.66% to $177.28 from a previous close of $191.99. The divergence between the +58.44% one-year gain and the -37.20% six-month loss is a classic momentum breakdown — the rally was front-loaded into the first half of the year, and the second half has been a persistent distribution phase, with the 1-month relative strength versus SPY at -16.85 percentage points and 3-month relative strength at -11.60 points. Volume of roughly 12.7 million shares on a down day, combined with a short ratio of just 1.19, suggests selling is being driven by long liquidation and profit-taking rather than a squeeze setup; the absence of heavy short interest removes a potential near-term catalyst for a violent rebound.
Key technical levels are unusually wide given the stock's beta of 3.618 — roughly 3.6x the market's volatility, which demands materially smaller position sizing and wider stops than a typical Industrials name. Support sits at the 52-week low of $75.70, with the recent November 5 close of $167.52 acting as the first line of defense; a breakdown below that level would open the door to a retest of the $150s and potentially the low-$100s, consistent with the analyst low target of $102. Resistance is anchored at the 52-week high of $351.28, with intermediate supply in the $230-$290 zone where the stock repeatedly failed in September and October; a decisive reclaim of $230+ would signal the correction is over, while a break of $167.52 would confirm the downtrend. Given the -52.65% max drawdown and 3.6 beta, volatility-adjusted position sizing is essential — a 1% portfolio allocation here carries roughly the risk of a 3.6% position in the S&P 500.
Beta
3.62
3.62x market volatility
Max Drawdown
-58.8%
Largest decline past year
52-Week Range
$76-$351
Price range past year
Annual Return
+52.5%
Cumulative gain past year
| Period | BE Return | S&P 500 |
|---|---|---|
| 1m | -40.3% | -9.7% |
| 3m | -29.3% | -9.9% |
| 6m | -52.9% | -7.5% |
| 1y | +52.5% | +4.7% |
| ytd | +44.3% | +1.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BE Fundamental Analysis
Revenue is inflecting sharply upward: Q3 2026 revenue hit $1.236 billion, up 138.1% year-over-year versus $519.0 million in Q3 2025, and the sequential trajectory is equally steep — $751.1 million in Q1, $1.066 billion in Q2, and $1.236 billion in Q3, implying a roughly 64% quarter-over-quarter increase from Q1 to Q3. The revenue mix is overwhelmingly product-driven, with Product at $1.074 billion of the disclosed segments, Installation at $89.0 million, Service at $67.6 million, and Electricity at $9.8 million, meaning the growth is hardware-led and tied to data-center and on-site generation deployments rather than recurring service revenue. The multi-quarter trend shows acceleration rather than deceleration — Q4 2025 revenue was $777.7 million and Q3 2025 was $519.0 million — which supports the bull case that AI-driven power demand is translating into real shipments, though the concentration in product revenue raises execution and working-capital risk if deployments slip.
Profitability has swung from marginal losses to robust margins: Q3 2026 net income was $250.3 million (a 20.25% net margin) versus a net loss of $23.1 million in Q3 2025, and gross margin expanded to 33.75% from 29.22% a year earlier, with Q2 2026 at 33.38% and Q1 2026 at 30.03% showing a clear upward trajectory. Operating income reached $225.4 million in Q3 2026 (18.24% operating margin) versus just $7.8 million a year ago, and EBITDA of $271.1 million compares to $4.6 million in the prior-year quarter — a dramatic operating leverage story as revenue scaled against a largely fixed cost base. The 33.75% gross margin is respectable for capital-intensive electrical equipment but below best-in-class industrial peers, leaving room for further expansion if service and electricity revenue mix grows; the trailing net margin of -4.37% in the key metrics reflects the loss-making 2025 quarters still in the TTM window, so the forward profitability picture is materially better than the trailing figures suggest.
Balance-sheet and cash-flow quality is the weak link in the story: debt-to-equity stands at 3.89x, ROE is -11.51% on a trailing basis, and Q3 2026 free cash flow was -$180.6 million despite $250.3 million of net income, driven by a $356.0 million working-capital drain (inventory -$170.4 million, receivables -$175.2 million) and $153.5 million of capex. The company does hold $2.51 billion in cash at quarter-end and a current ratio of 5.98, so liquidity is not an immediate concern, but the TTM free cash flow of $440.2 million masks the quarterly volatility (Q2 2026 FCF was +$174.8 million, Q1 +$47.5 million, Q3 -$180.6 million). The combination of high leverage, negative quarterly FCF, and heavy working-capital swings means Bloom remains dependent on its cash buffer and continued access to capital markets to fund growth — a genuine risk if the backlog conversion slows.
Quarterly Revenue
$1.2B
2026-09
Revenue YoY Growth
+138.1%
YoY Comparison
Gross Margin
33.8%
Latest Quarter
Free Cash Flow
$436814000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BE Overvalued?
Because trailing net income is negative (TTM EPS of -$0.0042 and a trailing PE of -234.8x), the PE ratio is not a meaningful primary metric; instead, the PS ratio of 10.32x and EV/Sales of 14.91x are the appropriate anchors, supplemented by the forward PE of 33.30x. The gap between the negative trailing PE and the 33.3x forward PE implies the market expects a dramatic earnings inflection — consensus estimated EPS of $13.78 versus essentially zero trailing earnings — which is a very high bar and leaves little room for execution disappointment. EV/EBITDA of 1,068.6x is distorted by the trailing loss quarters and should be disregarded in favor of the forward earnings framework.
Against the Industrials/Electrical Equipment sector, Bloom's 10.32x PS and 14.91x EV/Sales represent a substantial premium to typical capital-goods multiples in the low-to-mid single digits, and its 27.18x price-to-book versus a sector norm of roughly 2-4x is extreme. The premium is partially justified by the 138.1% revenue growth and 33.75% gross margin, which are far above sector norms, but the 3.89x debt-to-equity and negative trailing ROE of -11.51% cut against a clean quality premium. In short, investors are paying a growth-stock multiple for an industrial business — defensible only if the backlog converts and margins hold.
Historically, Bloom's own PS ratio has ranged from roughly 7x to 82x over the past several years, with the current 10.32x sitting in the lower-middle of that band and well below the 66.1x PS recorded at the Q3 2026 reporting date (a figure inflated by a much higher share price at the time). The stock's historical PE has swung between deeply negative and 5,298x, making PE history uninformative; on PS, the current multiple is closer to the 2024-era 8-9x range than to the 2026 peak, suggesting the recent sell-off has compressed valuation meaningfully even as fundamentals improved. That combination — falling multiple, rising earnings — is the classic setup for a potential re-rating if execution continues, but it also reflects the market's skepticism about the durability of the growth.
PE
-234.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 12x~184x
vs. Industry Avg
27.8x
Industry PE ~27.8x*
EV/EBITDA
1068.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on cash conversion and leverage. Q3 2026 free cash flow was -$180.6 million despite $250.3 million of net income, as working capital drained $356.0 million (inventory -$170.4 million, receivables -$175.2 million) alongside $153.5 million of capex, meaning growth is consuming cash rather than generating it. Debt-to-equity of 3.89x and a trailing ROE of -11.51% compound the concern, and revenue is heavily concentrated in product sales ($1.074 billion of Q3 segments versus $67.6 million service and $9.8 million electricity), so any slip in data-center deployments hits the top line directly. Liquidity is adequate with $2.51 billion of cash and a 5.98 current ratio, but the company remains dependent on capital-market access if backlog conversion slows.
Market and competitive risks are dominated by valuation compression and volatility. At 10.32x PS, 14.91x EV/Sales, and 27.18x P/B versus sector norms of low-to-mid single-digit sales multiples and 2-4x book, Bloom trades at a growth premium that assumes flawless execution of a $20 billion backlog and sustained 30%+ gross margins. A beta of 3.618 means the stock amplifies market moves roughly 3.6x, and the -52.65% max drawdown demonstrates how violently the multiple can contract; recent coverage highlights competition from GE Vernova, whose 96% order growth and $197 billion backlog make it a formidable AI-power rival. The 12 Hold ratings and a $102-$380 target spread (3.7x) confirm the Street has low conviction on terminal value, leaving the stock exposed to sector rotation away from high-multiple AI-infrastructure names.
The worst-case scenario is a chain in which backlog conversion slips, working-capital strain persists into Q4 with another negative FCF quarter, and gross margins compress below 30% as competition from gas turbines and grid solutions intensifies. That would force analysts toward the $102 low target and a de-rating toward industrial-peer multiples, a decline of roughly -42% from the current $177.28. A more severe outcome retests the 52-week low of $75.70, implying approximately -57% downside, consistent with the stock already having suffered a -52.65% max drawdown from its $351.28 high. Given the 3.618 beta, position sizing must be scaled accordingly — a 1% portfolio allocation carries roughly the risk of a 3.6% S&P 500 position.
FAQ
The most severe risk is cash conversion: Q3 2026 free cash flow was -$180.6 million despite $250.3 million of net income, driven by a $356.0 million working-capital drain and $153.5 million of capex, and a repeat in Q4 would directly challenge the growth thesis. Second is balance-sheet and earnings-quality risk, with debt-to-equity at 3.89x, trailing ROE of -11.51%, and trailing net margin of -4.37% reflecting the loss-making 2025 quarters still in the TTM window. Third is valuation and volatility risk — 10.32x PS, 27.18x P/B, a 3.618 beta, and a -52.65% max drawdown mean multiple compression alone can erase a year of gains, and the $102-$380 analyst target spread (3.7x) shows the Street has low conviction on terminal value. Fourth is competitive risk, most concretely GE Vernova's 96% order growth and $197 billion backlog competing for the same AI-power demand, plus grid and gas-turbine alternatives. Ranked by severity: cash conversion first, valuation compression second, competition third, leverage fourth.
The scenario framework assigns a 45% probability to the base case of $200-$283.85, in which backlog converts on schedule, gross margin holds in the 30-34% range, and free cash flow turns modestly positive by mid-2027, letting the stock grind from $177.28 toward the $283.85 average target. The bull case carries 30% probability and a $283.85-$380 target range, requiring positive Q4 free cash flow, gross margin above 33%, new large data-center contracts, and multiple expansion on AI-infrastructure enthusiasm. The bear case carries 25% probability and a $75.70-$102 range, triggered by a second consecutive negative-FCF quarter, gross margin below 30%, and share losses to GE Vernova and grid alternatives. The base case is most likely, and its key assumption is that working-capital swings ease enough to produce positive quarterly free cash flow by mid-2027 without a margin break — the single variable that most determines whether the stock re-rates or de-rates.
The trailing PE of -234.8x is meaningless because TTM EPS is -$0.0042, so the relevant anchors are the 10.32x PS, 14.91x EV/Sales, 27.18x P/B, and 33.30x forward PE on consensus EPS of $13.78. Against industrial peers, those are premium multiples — typical capital-goods names trade at low-to-mid single-digit sales multiples and 2-4x book — so on a relative basis BE is expensive. Against its own history, however, the 10.32x PS sits in the lower-middle of a 7x-82x band and far below the 66.1x recorded at the Q3 2026 reporting date, meaning the 43% drawdown has compressed the multiple even as earnings inflected upward. The market is therefore pricing in successful conversion of the ~$20 billion backlog and sustained 30%+ gross margins, but no longer pricing in perfection to the degree it did at the highs. Net: fairly valued to modestly undervalued versus its own history, still expensive versus peers — a growth premium that is defensible only if execution continues.
From a pure risk/reward standpoint, BE offers roughly +60.1% upside to the $283.85 average analyst target against downside to the $102 low target (-42%) and the $75.70 52-week low (-57%), so the reward is real but the downside is nearly as large in percentage terms. The operating evidence is strong — 138.1% revenue growth, 33.75% gross margin, $225.4 million of Q3 operating income versus $7.8 million a year ago — but Q3 free cash flow of -$180.6 million shows growth is currently consuming capital, and the 10.32x PS multiple leaves little margin for error. The 16 Buy / 12 Hold / 1 Sell split with a 2.17 recommendation mean is a 'buy with caveats' consensus, not a high-conviction call. It is a reasonable buy for growth-oriented investors who can tolerate a 3.618 beta and a -52.65% historical max drawdown, ideally scaled in on weakness toward the $150s rather than chased after a 15% single-day rebound. It is not a good buy for conservative or income-focused investors given the negligible dividend and negative quarterly FCF.
BE is best suited to a long-term growth allocation with a minimum holding period of 18-24 months, because the thesis depends on converting a ~$20 billion backlog into revenue and cash flow, and management's own base case has free cash flow turning positive only by mid-2027. The growth stage is early-commercial-scale — revenue of $1.236 billion in a single quarter against a $20.9 billion market cap — and earnings visibility is improving but still dependent on lumpy product shipments ($1.074 billion of Q3 revenue versus $67.6 million service). Volatility is extreme: beta of 3.618, a -52.65% max drawdown, and a 19.90% one-month decline mean short-term trading requires active risk management and wide stops around the $167.52 support level. The dividend is effectively zero (0.0045% yield), so there is no income rationale for holding. Short-term traders can play the $167.52-$230 range, but the fundamental case is a multi-year one that rewards patience and punishes oversized positions.

